# FDA Inspection 1246415 - Emily A. DiMango, M.D. - August 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/emily-a-dimango-md/93c446b7-105f-4e4c-af5e-d69dfb44087e
Source feed: FDA_Inspections

> FDA Inspection 1246415 for Emily A. DiMango, M.D. on August 13, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246415
- Company Name: Emily A. DiMango, M.D.
- Inspection Date: 2024-08-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1027368 - 2017-10-02](https://www.keypedia.com/records/fda_inspections/emily-a-dimango-md/0763556d-13e4-44ee-b15f-eb778450517d)

Company: https://www.keypedia.com/companies/emily-a-dimango-md/67c89259-5c4d-4f1d-a3c9-f1ef059170e1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c